EditorialDoes the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time
Section snippets
When SYNTAX score is not enough: commonly encountered pitfalls and limitations of SYNTAX score use in routinary practice
The SYNTAX score was originally introduced to facilitate discussion among cardiologists and surgeons regarding patients amenable to either PCI or CABG and therefore enrollable in the SYNTAX trial [18]. Following the presentation of the trial results, the score has gained a broader significance as an aid for decision-making and entered daily practice in many catheterization laboratories worldwide, with the endorsement of key opinion leaders in the field. However, a number of issues remain, which
Practicalities and considerations for skipping SYNTAX score calculation in selected cases
Among the key factors that have led to the development of the SYNTAX score there is the notion that even in patients with complex angiographic presentation, such as those with 3VD, a scale of complexity exists that distinguishes patients at lower risk (i.e., those amenable to spot stenting in three separate vessels) and patients at higher risk (i.e., those with chronic total occlusions of the left circumflex and the right coronary artery and diffuse, critical disease of the left anterior
Conclusions
The SYNTAX score is a nice step forward in the objectification of clinical decisions and no one should be so self-confident as to favor his own opinion as the only effective prognostic parameter. However, the SYNTAX score is imperfect, as it does not rely on clinical and functional information and, therefore, should not be idealized as a dogma. While time and variability issues should not contraindicate the use of the SYNTAX score, these problems can be addressed by calculating the score only
References (32)
- et al.
ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
J Am Coll Cardiol
(2011) - et al.
Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions
Am Heart J
(2011) - et al.
Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft
JACC Cardiovasc Interv
(2009) - et al.
Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization
JACC Cardiovasc Interv
(2011) - et al.
A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials
JACC Cardiovasc Interv
(2011) - et al.
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials
JACC Cardiovasc Interv
(2011) - et al.
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization
JACC Cardiovasc Interv
(2010) - et al.
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial
J Am Coll Cardiol
(2011) - et al.
Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study)
Am J Cardiol
(2010) - et al.
Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting
JACC Cardiovasc Interv
(2010)
Functional SYNTAX score for risk assessment in multivessel coronary artery disease
J Am Coll Cardiol
Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data
J Am Coll Cardiol
Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis
J Am Coll Cardiol
Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score
Cardiovasc Revasc Med
Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease
J Am Coll Cardiol
Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Eur Heart J
Cited by (9)
Risk Stratification for Percutaneous Coronary Intervention
2016, Interventional Cardiology ClinicsCitation Excerpt :Finally, once all lesions have been scored, the calculator requires indicating whether there are segments that fulfill the criteria for small vessel disease (Fig. 1). A significant issue that comes from this quite cumbersome process2 is the moderate interobserver variability of the SYNTAX score, with the scoring of bifurcations lesions representing the main source of inconsistency.3–9 The level of agreement improves after adequate training but remains generally more satisfactory in a core-laboratory setting than in daily routine.7,8,10
Combination of pulse wave velocity with clinical factors as a promising tool to predict major adverse cardiac events after percutaneous coronary intervention
2015, Journal of CardiologyCitation Excerpt :In previous studies, cfPWV showed additive predicting value beyond traditional risk factors [6,7]. Although the predictive value of SYNTAX score has been proven in several studies, it has several limitations, including interobserver variability, poor calibration, and not distinguishing ischemic-producing lesions [25]. Nevertheless, angiography is usually considered in selective patients with CAD related syndromes, which means SYNTAX score and other SYNTAX score-derived scores can only be used in limited patients.
Arterial stiffness assessed by brachial-ankle pulse wave velocity between patients with acute coronary syndrome and stable angina
2014, Experimental and Clinical Cardiology